SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001045969-02-001670
Filing Date
2002-10-09
Accepted
2002-10-09 10:04:54
Documents
7
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K d10ka.txt 10-K/A 22884
3 LICENSE AGREEMENT WITH SOLVARY PHARMACEUTICALS dex1033.txt EX-10.33 56605
4 LICENSE AGREEMENT WITH BIOSANTE PHARMACEUTICALS dex1034.txt EX-10.34 99438
5 AMENDMENT NO. 1 TO LICENSE AGREEMENT WITH BIOSANTE dex1035.txt EX-10.35 9944
6 AMENDMENT NO. 2 TO LICENSE AGREEMENT WITH BIOSANTE dex1036.txt EX-10.36 4559
7 AMENDMENT NO. 3 TO LICENSE AGREEMENT WITH BIOSANTE dex1037.txt EX-10.37 12191
8 SECTION 906 CEO AND CFO CERTIFICATION dex991.txt EX-99.1 1931
  Complete submission text file 0001045969-02-001670.txt   210175
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-20945 | Film No.: 02784680
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10